Impact of different dimethyl sulphoxide concentrations on cell recovery, viability and clonogenic potential of cryopreserved peripheral blood hematopoietic stem and progenitor cells

被引:21
作者
Smagur, A. [1 ,2 ]
Mitrus, I. [1 ,2 ]
Giebel, S. [1 ,2 ]
Sadus-Wojciechowska, M. [1 ,2 ]
Najda, J. [1 ,2 ]
Kruzel, T. [1 ,2 ]
Czerw, T. [1 ,2 ]
Gliwinska, J. [2 ,3 ]
Prokop, M. [2 ,3 ]
Glowala-Kosinska, M. [1 ,2 ]
Chwieduk, A. [1 ,2 ]
Holowiecki, J. [1 ,2 ]
机构
[1] Maria Sklodowska Curie Mem Canc Ctr, Dept Bone Marrow Transplantat, PL-44101 Gliwice, Poland
[2] Inst Oncol, Gliwice Branch, Gliwice, Poland
[3] Maria Sklodowska Curie Mem Canc Ctr, Analyt & Clin Biochem Dept, PL-44101 Gliwice, Poland
关键词
autologous transplantation; cryopreservation; dimethyl sulphoxide; leukapheresis; peripheral blood hematopoietic stem and progenitor cells; UMBILICAL-CORD BLOOD; BONE-MARROW TRANSPLANTATION; LONG-TERM CRYOPRESERVATION; 10-PERCENT DIMETHYLSULFOXIDE; HEMATOLOGIC RECONSTITUTION; POSTTHAW VIABILITY; CD34(+) CELLS; CFU-GM; ENGRAFTMENT; 5-PERCENT;
D O I
10.1111/j.1423-0410.2012.01657.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives The procedure of autologous hematopoietic stem/progenitor cell transplantation requires cryopreservation. Addition of DMSO is necessary to secure the viability of such cells, but this solvent is potentially toxic to stem cells' recipient. 10% DMSO solution is used by the majority of transplant centres. The aim of our study was to test if DMSO concentration might be reduced without negative impact on cell recovery and clonogenicity. Materials and Methods Samples were prospectively collected from 20 patients. Small volumes of leukapheresis products were frozen with different cryoprotective mixtures, containing 10%, 7 center dot 5%, 5% and 2 center dot 5% DMSO, respectively. The quality of cryoprotective mixtures was evaluated based on recovery, viability and clonogenic potential of hematopoietic stem cells after defreezing. Results Reduction in DMSO concentration to 7 center dot 5% or lower was associated with decreased recovery of nucleated cells. In contrast, the number of colonies was highest for 7 center dot 5% DMSO with significant differences when compared to 10%DMSO solution. Conclusion Reduction in DMSO concentration from 10% to 7 center dot 5% may have favourable impact on hematopoietic recovery after autologous transplantation. The findings require confirmation in a clinical setting.
引用
收藏
页码:240 / 247
页数:8
相关论文
共 44 条
  • [1] Autologous transplantation:: the viable transplanted CD34+ cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34+ cell dose measured pre-freeze in patients that receive more than 2 x 106 CD34+ cells/kg
    Abrahamsen, JF
    Wentzel-Larsen, T
    Bruserud, O
    [J]. CYTOTHERAPY, 2004, 6 (04) : 356 - 362
  • [2] Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide
    Abrahamsen, JF
    Rusten, L
    Bakken, AM
    Bruserud, O
    [J]. TRANSFUSION, 2004, 44 (05) : 785 - 789
  • [3] Cryopreserving human peripheral blood progenitor cells with 5-percent rather than 10-percent DMSO results in less apoptosis and necrosis in CD34+cells
    Abrahamsen, JF
    Bakken, AM
    Bruserud, O
    [J]. TRANSFUSION, 2002, 42 (12) : 1573 - 1580
  • [4] Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation
    Akkok, Cigdem A.
    Liseth, Knut
    Nesthus, Ingerid
    Lokeland, Turid
    Tefre, Kari
    Bruserud, Oystein
    Abrahamsen, Jenny F.
    [J]. TRANSFUSION, 2008, 48 (05) : 877 - 883
  • [5] Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells
    Akkok, Cigdem A.
    Holte, Mette R.
    Tangen, Jon M.
    Ostenstad, Bjorn
    Bruserud, Oystein
    [J]. TRANSFUSION, 2009, 49 (02) : 354 - 361
  • [6] Is there a scientific basis for a recommended standardization of collection and cryopreservation of peripheral blood stem cell grafts?
    Akkok, Cigdem Akalin
    Liseth, Knut
    Melve, Guro Kristin
    Ersvaer, Elisabeth
    Hervig, Tor
    Bruserud, Oystein
    [J]. CYTOTHERAPY, 2011, 13 (08) : 1013 - 1024
  • [7] No differences in colony formation of peripheral blood stem cells frozen with 5% or 10% dimethyl sulfoxide
    Bakken, AM
    Bruserud, O
    Abrahamsen, JF
    [J]. JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2003, 12 (03): : 351 - 358
  • [8] Bakken Anne Margrethe, 2006, Curr Stem Cell Res Ther, V1, P47, DOI 10.2174/157488806775269179
  • [9] The EBMT activity survey 2009: trends over the past 5 years
    Baldomero, H.
    Gratwohl, M.
    Gratwohl, A.
    Tichelli, A.
    Niederwieser, D.
    Madrigal, A.
    Frauendorfer, K.
    [J]. BONE MARROW TRANSPLANTATION, 2011, 46 (04) : 485 - 501
  • [10] Cryopreservation An emerging paradigm change
    Baust, John G.
    Gao, Dayong
    Baust, John M.
    [J]. ORGANOGENESIS, 2009, 5 (03) : 90 - 96